Literature DB >> 6262369

Multiple-antigen slide test for detection of immunoglobulin M antibodies in newborn and infant sera by immunofluorescence.

D Gallo, J L Riggs, J Schachter, R W Emmons.   

Abstract

A microimmunofluorescence test was evaluated for use in measuring immunoglobulin M (IgM) antibodies in infant sera to five of the agents implicated in congenital and neonatal disease. Pen point dots of Toxoplasma gondii, cytomegalovirus, rubella virus, herpes simplex virus, and chlamydial cell culture antigens were applied to each circle of eight-circle printed slides. These multiple-antigen slides greatly facilitated the screening of 607 sera from infants and 117 sera from mothers for the presence of IgM antibody to these agents. Forty sera could be examined microscopically in approximately 30 min. All sera reacting with one or more antigens were tested for rheumatoid factor by the latex method, absorbed with glutaraldehyde-cross-linked human IgG, and retested for the presence of IgM antibody. IgM antibody to cytomegalovirus was demonstrated in sera from four newborns, but IgM antibody to rubella virus could not be detected until 21 days after birth, although rubella virus was isolated from sera from five younger infants. This may indicate that rubella IgM levels in many congenitally infected newborns are too low to be measured by the immunofluorescence method. Five percent of the sera from infants in this study possessed demonstrable IgM antibody to one of the antigens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262369      PMCID: PMC273849          DOI: 10.1128/jcm.13.4.631-636.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.

Authors:  J A Zaia; M N Oxman
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

Review 2.  Congenital cytomegalovirus.

Authors:  J B Hanshaw; J A Dudgeon
Journal:  Major Probl Clin Pediatr       Date:  1978

3.  Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence.

Authors:  H Schmitz; R Haas
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

5.  Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test.

Authors:  S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1970-09       Impact factor: 5.258

6.  Specific immunoglobulins in infants with the congenital rubella syndrome.

Authors:  J E Cradock-Watson; M K Ridehalgh
Journal:  J Hyg (Lond)       Date:  1976-02

7.  A rapid immunofluorescent procedure for the detection of specific IgG and IgM antibody in sera using Staphylococcus aureus and latex-IgG as absorbents.

Authors:  S Chantler; E Devries; P R Allen; B A Hurn
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

8.  Simplified serological test for antibodies to Chlamydia trachomatis.

Authors:  B J Thomas; P Reeve; J D Oriel
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

Review 9.  Herpes simplex infection of the fetus and newborn.

Authors:  J B Hanshaw; J A Dudgeon
Journal:  Major Probl Clin Pediatr       Date:  1978

10.  Comparison of immunofluorescence and immunoperoxidase staining for identification of rubella virus isolates.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

View more
  9 in total

1.  Elimination of Fc receptor binding of human immunoglobulin G in immunofluorescence assays for herpes simplex virus antibodies.

Authors:  D Gallo
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

2.  Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation?

Authors:  N E Cremer; V L Devlin; J L Riggs; S J Hagens
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

3.  Improved immunofluorescence antigens for detection of immunoglobulin M antibodies to Epstein-Barr viral capsid antigen and antibodies to Epstein-Barr virus nuclear antigen.

Authors:  D Gallo; K H Walen; J L Riggs
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

4.  Improved serological diagnosis of rubella.

Authors:  N E Cremer; S J Hagens; R Fukuchi
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

5.  Antibody response to cytomegalovirus polypeptides captured by monoclonal antibodies on the solid phase in enzyme immunoassays.

Authors:  N E Cremer; C K Cossen; G R Shell; L Pereira
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

6.  Solid-phase immunosorbent technique for rapid detection of Rift Valley fever virus immunoglobulin M by hemagglutination inhibition.

Authors:  A K Soliman; B A Botros; J C Morrill
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

7.  Rapid diagnosis of respiratory syncytial virus infection by antigen immunofluorescence detection with monoclonal antibodies and immunoglobulin M immunofluorescence test.

Authors:  Z Kadi; S Dali; S Bakouri; A Bouguermouh
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

8.  Use of monoclonal antibodies to human immunoglobulin M in "capture" assays for measles and rubella immunoglobulin M.

Authors:  B Forghani; C K Myoraku; N J Schmidt
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

9.  Broadly reactive immunofluorescence test for measurement of immunoglobulin M and G antibodies to Ureaplasma urealyticum in infant and adult sera.

Authors:  D Gallo; K W Dupuis; N J Schmidt; G E Kenny
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.